Figure 1.
Structural models of wild type and mutant PNPLA3. Structural models of normal (Ile148) and mutant (Met148, associated with increased hepatic triglyceride content) PNPLA3 are shown in the left and right panels, respectively. This change effectively blocks substrate access to the catalytic dyad seen at Ser47 and Asp166. Adapted from He et al[8] used under Creative Commons-BY licensing.